Dr. Gritsman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Morris Park Avenue
Chanin 410A
Bronx, NY 10461
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
New York University School of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2002 - 2025
MA State Medical License 2004 - 2015
Clinical Trials
- A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 120 citationsAxicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma inclu...Ahmed Abbasi, Stephen Peeke, Nishi Shah, Jennat Mustafa, Fariha Khatun
Journal of Hematology & Oncology. 2020-01-03 - 55 citationsIL1RAP potentiates multiple oncogenic signaling pathways in AML.Kelly Mitchell, Laura Barreyro, Tihomira I. Todorova, Samuel J. Taylor, Iléana Antony-Debré
The Journal of Experimental Medicine. 2018-06-04 - 22 citationsPI3K alpha and delta promote hematopoietic stem cell activationShayda Hemmati, Taneisha Sinclair, Meng Tong, Boris Bartholdy, Rachel Okabe
JCI Insight. 2019-07-11
Abstracts/Posters
- Class I PI3K Is Required for HSC DifferentiationKira Gritsman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma CohortKira Gritsman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Einstein Researchers Use $10M Grant to Investigate Aggressive Breast Cancer with Disproportionate Impact on Black WomenOctober 18th, 2022- Haploinsufficiency of the Essential Gene Rps12 Causes Defects in Erythropoiesis and Hematopoietic Stem Cell MaintenanceJune 9th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
